VEGFA and glioma: Our present study explored the feasibility of using the multiple flip angle approach to estimate kio during treatment of murine glioma using a combination therapy of bevacizumab, a monoclonal antibody against VEGF, and fluorouracil (5FU), a cytotoxic chemotherapeutic agent.